Teleflex (TFX) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Teleflex Revenue Highlights

Latest Revenue (Y)

$2.97B

Latest Revenue (Q)

$764.38M

Main Segment (Y)

Vascular Access

Main Geography (Y)

Americas Segment

Teleflex Revenue by Period

Teleflex Revenue by Year

Date	Revenue	Change
2023-12-31	$2.97B	6.57%
2022-12-31	$2.79B	-0.66%
2021-12-31	$2.81B	10.74%
2020-12-31	$2.54B	-2.24%
2019-12-31	$2.60B	6.00%
2018-12-31	$2.45B	14.07%
2017-12-31	$2.15B	14.90%
2016-12-31	$1.87B	3.22%
2015-12-31	$1.81B	-1.64%
2014-12-31	$1.84B	8.46%
2013-12-31	$1.70B	9.37%
2012-12-31	$1.55B	1.45%
2011-12-31	$1.53B	-15.14%
2010-12-31	$1.80B	-4.67%
2009-12-31	$1.89B	-21.93%
2008-12-31	$2.42B	25.16%
2007-12-31	$1.93B	-26.92%
2006-12-31	$2.65B	5.26%
2005-12-25	$2.51B	1.17%
2004-12-26	$2.49B	8.89%
2003-12-28	$2.28B	9.93%
2002-12-29	$2.08B	8.99%
2001-12-31	$1.91B	7.96%
2000-12-31	$1.76B	10.20%
1999-12-26	$1.60B	11.37%
1998-12-27	$1.44B	25.47%
1997-12-28	$1.15B	23.05%
1996-12-29	$931.20M	2.03%
1995-12-31	$912.70M	12.30%
1994-12-25	$812.70M	21.88%
1993-12-26	$666.80M	-

Teleflex generated $2.97B in revenue during NA 2023, up 6.57% compared to the previous quarter, and up 121.49% compared to the same period a year ago.

Teleflex Revenue by Quarter

Date	Revenue	Change
2024-09-29	$764.38M	1.96%
2024-06-30	$749.69M	1.60%
2024-03-31	$737.85M	-4.66%
2023-12-31	$773.91M	3.69%
2023-10-01	$746.39M	0.42%
2023-07-02	$743.26M	4.55%
2023-04-02	$710.93M	-6.21%
2022-12-31	$758.00M	10.37%
2022-09-25	$686.79M	-2.52%
2022-06-26	$704.54M	9.79%
2022-03-27	$641.72M	-15.78%
2021-12-31	$761.91M	8.81%
2021-09-26	$700.25M	-1.85%
2021-06-27	$713.47M	12.55%
2021-03-28	$633.92M	-10.86%
2020-12-31	$711.18M	13.19%
2020-09-27	$628.30M	10.80%
2020-06-28	$567.03M	-10.09%
2020-03-29	$630.64M	-7.39%
2019-12-31	$680.95M	5.03%
2019-09-29	$648.32M	-0.64%
2019-06-30	$652.51M	6.34%
2019-03-31	$613.58M	-4.37%
2018-12-31	$641.62M	5.24%
2018-09-30	$609.67M	-0.03%
2018-07-01	$609.87M	3.85%
2018-04-01	$587.23M	-1.32%
2017-12-31	$595.11M	11.30%
2017-10-01	$534.70M	1.15%
2017-07-02	$528.61M	8.35%
2017-04-02	$487.88M	-5.07%
2016-12-31	$513.93M	12.79%
2016-09-25	$455.65M	-3.78%
2016-06-26	$473.55M	11.45%
2016-03-27	$424.89M	-12.30%
2015-12-31	$484.50M	9.19%
2015-09-27	$443.71M	-1.84%
2015-06-28	$452.05M	5.27%
2015-03-29	$429.43M	-9.79%
2014-12-31	$476.01M	4.12%
2014-09-28	$457.17M	-2.34%
2014-06-29	$468.11M	6.74%
2014-03-30	$438.55M	-2.66%
2013-12-31	$450.54M	8.88%
2013-09-29	$413.80M	-1.49%
2013-06-30	$420.06M	1.99%
2013-03-31	$411.88M	-1.71%
2012-12-31	$419.06M	13.86%
2012-09-30	$368.05M	-3.99%
2012-07-01	$383.33M	-1.14%
2012-04-01	$387.76M	-5.82%
2011-12-31	$411.73M	10.71%
2011-09-25	$371.89M	-4.96%
2011-06-26	$391.29M	0.68%
2011-03-27	$388.66M	-18.32%
2010-12-31	$475.84M	7.41%
2010-09-26	$442.99M	-4.05%
2010-06-27	$461.68M	5.78%
2010-03-28	$436.46M	-15.25%
2009-12-31	$515.00M	11.60%
2009-09-27	$461.48M	-4.47%
2009-06-28	$483.06M	2.85%
2009-03-29	$469.68M	-21.26%
2008-12-31	$596.46M	0.10%
2008-09-28	$595.88M	-4.52%
2008-06-29	$624.09M	3.24%
2008-03-30	$604.52M	-978.76%
2007-12-31	$-68.79M	-

Teleflex generated $764.38M in revenue during Q3 2024, up 1.96% compared to the previous quarter, and up 102.84% compared to the same period a year ago.

Teleflex Revenue Breakdown

Teleflex Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Anesthesia	$389.96M	$388.89M	$380.14M	$302.29M	$338.41M
Surgical	$427.36M	$392.92M	$377.76M	$317.20M	$370.07M
Vascular Access	$708.04M	$683.61M	$700.24M	$657.70M	$600.87M
Other	$291.90M	$285.15M	$336.58M	$367.26M	$347.27M
Interventional	$511.43M	$445.02M	$427.50M	$382.44M	$427.56M
Interventional Urology	$319.79M	$322.83M	$341.66M	$290.02M	$290.45M
Oem	-	$272.62M	$245.68M	$220.25M	$220.72M

Teleflex's latest annual revenue breakdown by segment (product or service), as of Dec 23: Vascular Access (26.73%), Interventional (19.31%), Surgical (16.14%), Anesthesia (14.72%), Interventional Urology (12.07%), and Other (11.02%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Mar 24	Dec 23	Oct 23	Jul 23	Apr 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
Surgical	$111.75M	$111.30M	$105.52M	$109.58M	$112.81M	$105.95M	$99.02M	$110.45M	$93.12M	$99.64M	$89.70M	$106.35M	$92.83M	$98.19M	$80.39M	$92.27M	$82.22M	$67.28M	$75.43M	$95.16M
Interventional	$149.87M	$141.16M	$134.66M	$135.67M	$134.09M	$124.78M	$116.90M	$125.08M	$108.74M	$114.34M	$96.86M	$114.94M	$104.30M	$112.08M	$96.17M	$106.73M	$93.19M	$82.59M	$99.93M	$112.71M
Interventional Urology	$83.39M	$83.10M	$79.74M	$92.97M	$73.62M	$77.82M	$75.38M	$89.15M	$78.97M	$79.82M	$74.89M	$92.95M	$83.11M	$92.24M	$73.36M	$93.91M	$81.77M	$40.09M	$74.19M	$89.14M
Anesthesia	$101.15M	$102.49M	$96.35M	$98.17M	$97.61M	$100.84M	$93.33M	$99.63M	$97.61M	$104.69M	$86.96M	$102.78M	$97.07M	$95.43M	$84.86M	$86.09M	$75.65M	$64.87M	$75.70M	$85.31M
Other	$54.76M	$41.70M	$52.52M	$68.26M	$76.03M	$75.95M	$71.65M	$73.59M	$69.91M	$72.14M	$69.51M	$84.68M	$83.38M	$86.84M	$81.68M	$98.10M	$86.02M	$91.41M	$91.74M	$89.37M
Vascular Access	$180.90M	$181.10M	$181.35M	$186.69M	$169.92M	$173.78M	$177.65M	$186.42M	$167.15M	$163.91M	$166.13M	$193.05M	$175.48M	$167.74M	$163.97M	$182.45M	$160.05M	$164.96M	$150.26M	$154.65M
Oem	-	-	$87.70M	$82.31M	$84.13M	$77.00M	$73.68M	$71.29M	$70.00M	$57.66M	$67.15M	$64.08M	$60.96M	$53.49M	$51.63M	$63.39M	-	-	-	-

Teleflex's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Vascular Access (26.53%), Interventional (21.98%), Surgical (16.39%), Anesthesia (14.84%), Interventional Urology (12.23%), and Other (8.03%).

Teleflex Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Americas Segment	$1.72B	-	-	-	-
Asia Segment	$346.90M	-	-	-	-
EMEA Segment	$586.25M	-	-	-	-
Oem	$326.01M	-	-	-	-
UNITED STATES	-	$1.79B	$1.77B	$1.57B	$1.61B
Europe	-	$622.34M	$665.00M	$646.58M	$652.07M
Asia And Asia Pacific	-	$270.75M	$263.02M	$230.27M	$241.28M
All Other	-	$111.48M	$112.05M	$93.17M	$95.77M

Teleflex's latest annual revenue breakdown by geography, as of Dec 23: Americas Segment (57.67%), EMEA Segment (19.71%), Asia Segment (11.66%), and Oem (10.96%).

Quarterly Revenue by Country

Country	Sep 24	Jun 24	Mar 24	Dec 23	Oct 23	Jul 23	Apr 23	Sep 22	Jun 22	Mar 22	Sep 21	Jun 21	Mar 21	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19
Oem	$82.56M	$88.83M	$87.70M	$49.40M	$55.83M	$63.39M	$54.61M	$55.44M	$56.43M	$54.24M	-	-	-	-	-	-	-	-	-	-
EMEA	$150.22M	$147.06M	$159.66M	$135.65M	$131.64M	$156.12M	$145.93M	$140.52M	$147.05M	$154.54M	-	-	-	-	-	-	-	-	-	-
Asia	$98.26M	$87.00M	$84.21M	$68.21M	$67.07M	$53.13M	$80.46M	$77.86M	$75.23M	$60.78M	-	-	-	-	-	-	-	-	-	-
Americas Segment	$433.33M	$426.81M	$406.29M	$450.62M	$428.21M	$424.64M	$411.86M	$405.04M	$412.74M	$377.96M	$417.33M	$414.79M	$375.49M	-	-	-	-	-	-	-
OEM Segment	-	-	$87.70M	$82.31M	$84.13M	$77.00M	$71.29M	$70.00M	$57.66M	$64.08M	$60.96M	$53.49M	-	-	-	-	-	-	-	-
Asia Segment	-	-	$84.21M	$88.34M	$93.15M	$86.68M	$78.73M	$82.03M	$76.61M	$69.19M	$74.96M	$80.60M	$63.69M	-	-	-	-	-	-	-
EMEA Segment	-	-	$159.66M	$152.37M	$142.72M	$147.81M	$143.34M	$128.44M	$145.19M	$136.91M	$143.88M	$157.13M	$141.25M	-	-	-	-	-	-	-
Vascular North America	-	-	-	-	-	-	-	-	-	-	-	-	-	$375.04M	$312.49M	$358.00M	$399.95M	$374.49M	$373.80M	$344.02M

Teleflex's latest quarterly revenue breakdown by geography, as of Sep 24: Americas Segment (56.69%), EMEA (19.65%), Asia (12.86%), and Oem (10.80%).

Teleflex Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
BDX	Becton, Dickinson and Company	$19.37B	$4.99B
ALC	Alcon	$10.09B	$2.46B
RMD	ResMed	$4.69B	$1.22B
HOLX	Hologic	$4.03B	$1.01B
COO	Cooper Companies	$3.59B	$1.00B
ATR	AptarGroup	$3.49B	$909.29M
TFX	Teleflex	$2.97B	$764.38M
WST	West Pharmaceutical Services	$2.95B	$746.90M
NVST	Envista	$2.57B	$884.70M
ICUI	ICU Medical	$2.26B	$589.13M
HAE	Haemonetics	$1.31B	$336.17M
MMSI	Merit Medical Systems	$1.26B	$339.85M
ANGO	AngioDynamics	$303.91M	$67.49M

TFX Revenue FAQ

What is Teleflex’s yearly revenue?

Teleflex's yearly revenue for 2023 was $2.97B, representing an increase of 6.57% compared to 2022. The company's yearly revenue for 2022 was $2.79B, representing a decrease of -0.66% compared to 2021. TFX's yearly revenue for 2021 was $2.81B, representing an increase of 10.74% compared to 2020.

What is Teleflex’s quarterly revenue?

Teleflex's quarterly revenue for Q3 2024 was $764.38M, a 1.96% increase from the previous quarter (Q2 2024), and a 2.41% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $749.69M, a 1.60% increase from the previous quarter (Q1 2024), and a 0.87% increase year-over-year (Q2 2023). TFX's quarterly revenue for Q1 2024 was $737.85M, a -4.66% decrease from the previous quarter (Q4 2023), and a 3.79% increase year-over-year (Q1 2023).

What is Teleflex’s revenue growth rate?

Teleflex's revenue growth rate for the last 3 years (2021-2023) was 5.87%, and for the last 5 years (2019-2023) was 14.61%.

What are Teleflex’s revenue streams?

Teleflex's revenue streams in c 23 are Anesthesia, Surgical, Vascular Access, Other, Interventional, and Interventional Urology. Anesthesia generated $389.96M in revenue, accounting 14.72% of the company's total revenue, up 0.27% year-over-year. Surgical generated $427.36M in revenue, accounting 16.14% of the company's total revenue, up 8.77% year-over-year. Vascular Access generated $708.04M in revenue, accounting 26.73% of the company's total revenue, up 3.57% year-over-year. Other generated $291.9M in revenue, accounting 11.02% of the company's total revenue, up 2.37% year-over-year. Interventional generated $511.43M in revenue, accounting 19.31% of the company's total revenue, up 14.92% year-over-year. Interventional Urology generated $319.78M in revenue, accounting 12.07% of the company's total revenue, down -0.94% year-over-year.

What is Teleflex’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Teleflex was Vascular Access. This segment made a revenue of $708.04M, representing 26.73% of the company's total revenue.